VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 146 filers reported holding VIKING THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | 0.0% | 416 | 0.0% | 0.00% | – |
| Q2 2022 | $4,000 | -20.0% | 416 | -3.7% | 0.00% | – |
| Q1 2022 | $5,000 | +400.0% | 432 | +2600.0% | 0.00% | – |
| Q4 2021 | $1,000 | -96.9% | 16 | -99.4% | 0.00% | -100.0% |
| Q3 2021 | $32,000 | +113.3% | 2,904 | +1.0% | 0.00% | – |
| Q2 2021 | $15,000 | -6.2% | 2,874 | -0.6% | 0.00% | – |
| Q1 2021 | $16,000 | +23.1% | 2,892 | +15.2% | 0.00% | -100.0% |
| Q4 2020 | $13,000 | -7.1% | 2,511 | -1.4% | 0.00% | 0.0% |
| Q3 2020 | $14,000 | -17.6% | 2,547 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $17,000 | +41.7% | 2,547 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $12,000 | -55.6% | 2,547 | -20.0% | 0.00% | -50.0% |
| Q4 2019 | $27,000 | +28.6% | 3,182 | +1.7% | 0.00% | +100.0% |
| Q3 2019 | $21,000 | +250.0% | 3,129 | +421.5% | 0.00% | 0.0% |
| Q1 2019 | $6,000 | -75.0% | 600 | -81.0% | 0.00% | 0.0% |
| Q4 2018 | $24,000 | +140.0% | 3,158 | +426.3% | 0.00% | – |
| Q3 2018 | $10,000 | -77.3% | 600 | -87.0% | 0.00% | -100.0% |
| Q2 2018 | $44,000 | +633.3% | 4,600 | +666.7% | 0.00% | +100.0% |
| Q1 2016 | $6,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 450,900 | $2,624,000 | 0.85% |
| Sio Capital Management, LLC | 709,780 | $4,131,000 | 0.82% |
| KNOTT DAVID M | 218,102 | $1,269,000 | 0.74% |
| ArrowMark Colorado Holdings LLC | 7,988,635 | $46,494,000 | 0.44% |
| Park West Asset Management LLC | 1,457,507 | $8,483,000 | 0.33% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 1,657 | $10,000 | 0.18% |
| Virtus ETF Advisers LLC | 42,507 | $247,000 | 0.13% |
| Cornerstone Capital, Inc. | 125,465 | $730,000 | 0.10% |
| L & S Advisors Inc | 114,988 | $669,000 | 0.09% |
| EXANE DERIVATIVES | 44,877 | $261,170,000 | 0.08% |